研究者業績
基本情報
- 所属
- 藤田医科大学 研究推進本部 神経・精神病態研究拠点 准教授
- 学位
- 博士(工学)(大阪大学)
- 研究者番号
- 00415564
- J-GLOBAL ID
- 201101000852528164
- researchmap会員ID
- B000001861
研究分野
1主要な経歴
11-
2025年7月 - 現在
-
2025年7月 - 現在
-
2022年4月 - 2025年6月
主要な委員歴
8-
2023年4月 - 2025年6月
-
2025年5月
-
2018年10月 - 2022年3月
受賞
1-
2020年8月
論文
73-
Acta neuropsychiatrica 25(4) 215-20 2013年8月 査読有り
-
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 38(8) 1409-25 2013年7月 査読有り
-
BMC research notes 6 203-203 2013年5月21日 査読有りBACKGROUND: The Grin1 (glutamate receptor, ionotropic, NMDA1) gene expresses a subunit of N-methyl-D-aspartate (NMDA) receptors that is considered to play an important role in excitatory neurotransmission, synaptic plasticity, and brain development. Grin1 is a candidate susceptibility gene for neuropsychiatric disorders, including schizophrenia, bipolar disorder, and attention deficit/hyperactivity disorder (ADHD). In our previous study, we examined an N-ethyl-N-nitrosourea (ENU)-generated mutant mouse strain (Grin1(Rgsc174)/Grin1+) that has a non-synonymous mutation in Grin1. These mutant mice showed hyperactivity, increased novelty-seeking to objects, and abnormal social interactions. Therefore, Grin1(Rgsc174)/Grin1+ mice may serve as a potential animal model of neuropsychiatric disorders. However, other behavioral characteristics related to these disorders, such as working memory function and sensorimotor gating, have not been fully explored in these mutant mice. In this study, to further investigate the behavioral phenotypes of Grin1(Rgsc174)/Grin1+ mice, we subjected them to a comprehensive battery of behavioral tests. RESULTS: There was no significant difference in nociception between Grin1(Rgsc174)/Grin1+ and wild-type mice. The mutants did not display any abnormalities in the Porsolt forced swim and tail suspension tests. We confirmed the previous observations that the locomotor activity of these mutant mice increased in the open field and home cage activity tests. They displayed abnormal anxiety-like behaviors in the light/dark transition and the elevated plus maze tests. Both contextual and cued fear memory were severely deficient in the fear conditioning test. The mutant mice exhibited slightly impaired working memory in the eight-arm radial maze test. The startle amplitude was markedly decreased in Grin1(Rgsc174)/Grin1+ mice, whereas no significant differences between genotypes were detected in the prepulse inhibition (PPI) test. The mutant mice showed no obvious deficits in social behaviors in three different social interaction tests. CONCLUSIONS: This study demonstrated that the Grin1(Rgsc174)/Grin1+ mutation causes abnormal anxiety-like behaviors, a deficiency in fear memory, and a decreased startle amplitude in mice. Although Grin1(Rgsc174)/Grin1+ mice only partially recapitulate symptoms of patients with ADHD, schizophrenia, and bipolar disorder, they may serve as a unique animal model of a certain subpopulation of patients with these disorders.
-
Frontiers in integrative neuroscience 7 76-76 2013年 査読有り
-
Scientific reports 3 1224-1224 2013年 査読有りToward a therapeutic intervention of lissencephaly, we applied a novel calpain inhibitor, SNJ1945. Peri-natal or post-natal treatment with SNJ1945 rescued defective neuronal migration in Lis1⁺/⁻ mice, impaired behavioral performance and improvement of ¹⁸F-FDG uptake. Furthermore, SNJ1945 improved the neural circuit formation and retrograde transport of NFG in Lis1⁺/⁻ mice. Thus, SNJ1945 is a potential drug for the treatment of human lissencephaly patients.
-
Journal of visualized experiments : JoVE (60) 2012年2月26日 査読有り
-
HIPPOCAMPUS 22(2) 117-121 2012年2月 査読有り
-
Hippocampus 22(2) 117-21 2012年2月 査読有り
-
Frontiers in behavioral neuroscience 6 58-58 2012年 査読有りPituitary adenylate cyclase-activating polypeptide (PACAP) is a neuropeptide acting as a neurotransmitter, neuromodulator, or neurotrophic factor. PACAP is widely expressed throughout the brain and exerts its functions through the PACAP-specific receptor (PAC(1)). Recent studies reveal that genetic variants of the PACAP and PAC(1) genes are associated with mental disorders, and several behavioral abnormalities of PACAP knockout (KO) mice are reported. However, an insufficient number of backcrosses was made using PACAP KO mice on the C57BL/6J background due to their postnatal mortality. To elucidate the effects of PACAP on neuropsychiatric function, the PACAP gene was knocked out in F1 hybrid mice (C57BL/6J × 129SvEv) for appropriate control of the genetic background. The PACAP KO mice were then subjected to a behavioral test battery. PACAP deficiency had no significant effects on neurological screen. As shown previously, the mice exhibited significantly increased locomotor activity in a novel environment and abnormal anxiety-like behavior, while no obvious differences between genotypes were shown in home cage (HC) activity. In contrast to previous reports, the PACAP KO mice showed normal prepulse inhibition (PPI) and slightly decreased depression-like behavior. Previous study demonstrates that the social interaction (SI) in a resident-intruder test was decreased in PACAP KO mice. On the other hand, we showed that PACAP KO mice exhibited increased SI in Crawley's three-chamber social approach test, although PACAP KO had no significant impact on SI in a HC. PACAP KO mice also exhibited mild performance deficit in working memory in an eight-arm radial maze (RM) and the T-maze (TM), while they did not show any significant abnormalities in the left-right discrimination task in the TM. These results suggest that PACAP has an important role in the regulation of locomotor activity, social behavior, anxiety-like behavior and, potentially, working memory.
-
The Journal of neuroscience : the official journal of the Society for Neuroscience 31(12) 4720-30 2011年3月23日 査読有り
-
PloS one 6(1) e15886 2011年1月18日 査読有り
-
NMDAR2B tyrosine phosphorylation regulates anxiety-like behavior and CRF expression in the amygdala.Molecular brain 3 37-37 2010年11月30日 査読有り
-
Molecular brain 2 35-35 2009年11月19日 査読有り
-
Molecular brain 1 11-11 2008年10月22日 査読有り
-
Biochemical and biophysical research communications 373(2) 298-302 2008年8月22日 査読有り
-
MOLECULAR PSYCHIATRY 12(11) 1026-1032 2007年11月 査読有り
-
Neuroscience letters 421(1) 47-51 2007年6月21日 査読有り
-
Behavioural brain research 180(1) 69-76 2007年6月4日 査読有り
-
JOURNAL OF NEURAL TRANSMISSION 113(9) 1337-1346 2006年9月 査読有り
-
The European journal of neuroscience 18(4) 879-86 2003年8月 査読有り
-
Journal of neurophysiology 90(1) 175-83 2003年7月 査読有り
-
Synapse (New York, N.Y.) 48(2) 57-65 2003年5月 査読有り
主要なMISC
51-
日本神経精神薬理学会年会・日本生物学的精神医学会年会・日本精神薬学会総会・学術集会合同年会プログラム・抄録集 50回・42回・4回 188-188 2020年8月
書籍等出版物
3主要な担当経験のある科目(授業)
10主要な所属学協会
5主要な共同研究・競争的資金等の研究課題
8-
日本学術振興会 科学研究費助成事業 基盤研究(C) 2023年4月 - 2026年3月
-
日本学術振興会 科学研究費助成事業 特別推進研究 2018年4月 - 2023年3月
-
日本学術振興会 科学研究費助成事業 基盤研究(C) 2018年4月 - 2021年3月